| Olga Mogen, | |
|
104 Centennial Dr Ste 101, Livingston, MT 59047-8101 | |
| (406) 222-5519 | |
| Not Available |
| Full Name | Olga Mogen |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 104 Centennial Dr Ste 101, Livingston, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598459109 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Olga Mogen, 1604 Mountain View Ln, Livingston, MT 59047-3812 Ph: () - | Olga Mogen, 104 Centennial Dr Ste 101, Livingston, MT 59047-8101 Ph: (406) 222-5519 |
News Archive
CDEX Inc. and All Business Machines, Inc. announce that the ValiMed™ MVS (Medication Validation System) and ID2 Meth Scanner™ product lines by CDEX have been placed on the ABMI GSA Contract Schedule. ValiMed MVS puts a technological safety net between the patient and errors made in the compounding of high risk medications and guards against narcotic diversion. Both are now available to the Government markets through the ABMI GSA Schedule.
Government cuts to alcohol taxes have had dramatic consequences for public health, including nearly 2000 more alcohol-related deaths in England since 2012, according to new research from the University of Sheffield's School of Health and Related Research.
Australian researchers have discovered a viral link which they believe may help explain high blood pressure during pregnancy (pre-eclampsia) and pre-term birth.
Gender matters when it comes to smoking cessation. Women are 31 percent less likely to quit smoking successfully, according to the National Institute of Drug Abuse, in part because nicotine replacement therapy is thought to be more effective in male smokers.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 1 days ago
Holly May, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 320 Alpenglow Ln, Livingston, MT 59047 Phone: 406-823-6414 | |
Livingston Health & Rehabilitation Center Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 510 S 14th St, Livingston, MT 59047 Phone: 406-222-0672 | |
Mark Robert Broadhead, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 510 S 14th St, Livingston, MT 59047 Phone: 406-222-0672 | |
Gary Dean Miller, P.T., CPED Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 315 S. Main St, Livingston, MT 59047 Phone: 406-222-4682 Fax: 406-222-4681 | |
Dr. Lexi Jade Klawitter, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 315 S Main St, Livingston, MT 59047 Phone: 406-222-4682 | |
Alison Shannon-lier, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 315 S Main St, Livingston, MT 59047 Phone: 406-222-4682 | |
Erika Suermann, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 510 S 14th St, Livingston, MT 59047 Phone: 406-222-0672 |